|
UCHL5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.810200E-02 |
| Stage1-vs-Stage3 |
8.597200E-01 |
| Stage1-vs-Stage4 |
1.575020E-01 |
| Stage2-vs-Stage3 |
1.430840E-01 |
| Stage2-vs-Stage4 |
2.724400E-02 |
| Stage3-vs-Stage4 |
2.827600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.7089663018055E-12 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
1.216220E-01 |
| Caucasian-vs-Asian |
5.335400E-01 |
| AfricanAmerican-vs-Asian |
8.023900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
9.299600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.00480000273262E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.693000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.868100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.393000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.200400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.255000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.718600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.998600E-01 |
| Classical-VS-Follicular |
7.680400E-03 |
| Classical-VS-Other |
6.059200E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.263710E-02 |
| Tall-VS-Other |
9.289000E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
2.247200E-01 |
| Follicular-VS-Normal |
1.62447832963153E-12 |
| Other-VS-Normal |
1.76439995946964E-09 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.257900E-02 |
|
|
